Stock GDRX GOODRX HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News GoodRx Holdings, Inc.

Equities

GDRX

US38246G1085

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
7.08 USD +1.72% Intraday chart for GoodRx Holdings, Inc. +5.20% +5.67%
Apr. 11 North American Morning Briefing : Stock Futures -2- DJ
Apr. 10 KeyBanc Upgrades GoodRx to Overweight From Sector Weight on Increased Conviction Around Monthly Active Customers, Sets $9 Price Target MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
GDRX Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
PR
GoodRx Announces Date for 2024 Investor Day
BU
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx
PR
GDRX Alert: Rosen, Skilled Investor Counsel, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GDRX
BU
GDRX Kessler Topaz Meltzer & Check, LLP Files A Securities Fraud Class Action Lawsuit Against GoodRX Holdings, Inc. And Encourages Investors With Losses To Contact The Firm
BU
GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call
BU
North American Morning Briefing : Stock Futures -2-
DJ
KeyBanc Upgrades GoodRx to Overweight From Sector Weight on Increased Conviction Around Monthly Active Customers, Sets $9 Price Target
MT
North American Morning Briefing : Traders Await -2-
DJ
North American Morning Briefing : Markets Steady -2-
DJ
GoodRx Shares Jump Following Wells Fargo Upgrade, Price Target Boost
MT
Top Premarket Gainers
MT
Wells Fargo Upgrades GoodRx Holdings to Overweight From Equalweight, Adjusts Price Target to $10 From $7.50
MT
Transcript : GoodRx Holdings, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 09:00 AM
GoodRx Interim CEO Extends Commitment to Company
BU
Deutsche Bank Adjusts GoodRx Price Target to $9 From $7, Maintains Hold Rating
MT
North American Morning Briefing : Stock Futures -2-
DJ
Goldman Sachs Raises GoodRx Holdings' Price Target to $7.50 From $6.50, Maintains Neutral Rating
MT
UBS Adjusts GoodRx Holdings Price Target to $8 From $5, Maintains Neutral Rating
MT
TD Cowen Adjusts Price Target on GoodRx Holdings to $14 From $12, Maintains Outperform Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GDRX Stock
  4. News GoodRx Holdings, Inc.